Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The trouble with TIGITs: How 'overenthusiasm' led to Big Pharma's risky $6B gamble
CPAP device
Biotech
Apnimed eyes FDA sleep apnea submission after positive results
AD109 met the trial's primary endpoint, reducing sleep apnea severity by a statistically significant 55.6% compared to baseline.
Darren Incorvaia
May 19, 2025 6:00am
Philips signs $1.1B settlement for CPAP personal injury claims
Apr 29, 2024 4:12pm
US court hands Philips final consent decree in CPAP recall
Apr 10, 2024 11:49am
ResMed launches new BiPAP machine for sleep apnea
Feb 13, 2024 10:24am
FDA counts another 111 deaths in 7K new Philips recall reports
Feb 2, 2024 11:52am
ResMed CPAP magnet warning earns FDA Class I recall tag
Jan 12, 2024 10:33am
